Eurofins Scientific SE (ERF) — Cash Flow Reinvestment Rate
Eurofins Scientific SE (ERF) has a Cash Flow Reinvestment Rate of 0.68x as of December 2025, reinvesting €538.70 Million (capex €538.70 Million ) from operating cash flow of €789.60 Million. Check cash flow quality index of Eurofins Scientific SE to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Eurofins Scientific SE Cash Flow Reinvestment Rate (2002–2025)
Historical reinvestment intensity for Eurofins Scientific SE across 24 annual periods. Explore ERF strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Eurofins Scientific SE (2002–2025)
Year-by-year capital reinvestment analysis for Eurofins Scientific SE. For live market cap and broader valuation context, see Eurofins Scientific SE stock valuation.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.59x | €762.00 Million | €1.29 Billion | €760.00 Million | ▼ -43.6% |
| 2024 | 1.04x | €1.37 Billion | €1.32 Billion | €528.40 Million | ▼ -13.8% |
| 2023 | 1.21x | €1.23 Billion | €1.02 Billion | €550.10 Million | ▼ -9.3% |
| 2022 | 1.33x | €1.52 Billion | €1.14 Billion | €660.20 Million | ▲ +281.6% |
| 2021 | 0.35x | €527.90 Million | €1.51 Billion | €519.50 Million | ▼ -51.4% |
| 2020 | 0.72x | €880.50 Million | €1.22 Billion | €355.50 Million | ▼ -49.5% |
| 2019 | 1.42x | €965.30 Million | €677.90 Million | €425.10 Million | ▼ -59.7% |
| 2018 | 3.53x | €1.92 Billion | €543.89 Million | €364.45 Million | ▼ -28.2% |
| 2017 | 4.92x | €1.99 Billion | €405.12 Million | €245.74 Million | ▲ +209.2% |
| 2016 | 1.59x | €591.48 Million | €371.84 Million | €199.68 Million | ▲ +172.0% |
| 2015 | 0.58x | €170.29 Million | €291.15 Million | €169.12 Million | ▼ -8.9% |
| 2014 | 0.64x | €136.16 Million | €212.17 Million | €134.52 Million | ▲ +4.9% |
| 2013 | 0.61x | €103.54 Million | €169.34 Million | €99.56 Million | ▲ +14.5% |
| 2012 | 0.53x | €71.64 Million | €134.16 Million | €71.64 Million | ▲ +9.3% |
| 2011 | 0.49x | €53.91 Million | €110.32 Million | €53.91 Million | ▲ +1.2% |
| 2010 | 0.48x | €41.00 Million | €84.94 Million | €41.00 Million | ▼ -32.0% |
| 2009 | 0.71x | €45.63 Million | €64.34 Million | €45.63 Million | ▼ -22.3% |
| 2008 | 0.91x | €54.80 Million | €60.04 Million | €54.80 Million | ▼ -24.9% |
| 2007 | 1.21x | €48.06 Million | €39.57 Million | €48.06 Million | ▲ +42.7% |
| 2006 | 0.85x | €25.68 Million | €30.18 Million | €25.68 Million | ▲ +28.4% |
| 2005 | 0.66x | €16.89 Million | €25.49 Million | €16.89 Million | ▲ +67.2% |
| 2004 | 0.40x | €9.26 Million | €23.37 Million | €9.26 Million | ▼ -58.5% |
| 2003 | 0.95x | €12.59 Million | €13.18 Million | €12.59 Million | ▲ +6.1% |
| 2002 | 0.90x | €10.35 Million | €11.51 Million | €10.35 Million | — |